The Ophthalmologist
  • Explore

    Explore

    • Latest
    • Insights
    • Case Studies
    • Opinion & Personal Narratives
    • Research & Innovations
    • Product Profiles

    Featured Topics

    • Anterior Segment
    • Glaucoma
    • Retina

    Issues

    • Latest Issue
    • Archive
  • Subspecialties
    • Cataract
    • Cornea
    • Glaucoma
    • Neuro-ophthalmology
    • Oculoplastics
    • Optometry
    • Pediatric
    • Retina
  • Business

    Business & Profession

    • Professional Development
    • Business and Entrepreneurship
    • Practice Management
    • Health Economics & Policy
  • Training & Education

    Career Development

    • Professional Development
    • Career Pathways

    Events

    • Webinars
    • Live Events
  • Events
    • Live Events
    • Webinars
  • Community

    People & Profiles

    • Power List
    • Voices in the Community
    • Authors & Contributors
  • Multimedia
    • Video
    • Campaigns & Insights
Subscribe
Subscribe

False

Advertisement
The Ophthalmologist / Issues / 2026 / August / Chinese Trial Validates Scleral Lenses
Health Economics and Policy Refractive News

Chinese Trial Validates Scleral Lenses

Large Chinese trial confirms strong visual outcomes with four-zone scleral lenses for irregular corneas

8/28/2026 3 min read

Share

  • Full Article
  • Summary
  • Takeaways
  • Report
  • Scorecard
  • Quiz
  • Poll
  • Topic Commentary

Clinical Report: Chinese Trial Validates Scleral Lenses

Overview

A multi-center clinical trial in China demonstrated that a four-zone scleral lens design provides visual rehabilitation for patients with irregular corneas. The study involved 138 adults and showed improvements in vision and comfort over three months.

Background

Scleral lenses are increasingly used for managing irregular corneas, yet most evidence comes from non-Asian populations. This study addresses the need for population-specific data, considering anatomical differences that may affect lens fitting and performance.

Data Highlights

OutcomeResult
Successful visual rehabilitation (≥0.20 logMAR improvement)97.7%
Eyes gaining two or more lines of vision98.5%
Median improvement in vision0.30 logMAR
Average lenses required per eye for optimal fit1.5
Participants wearing lenses ≥8 hours/day at 3 months~75%
Participants rating comfort and vision highly~90%

Key Findings

  • The study enrolled 138 adults with irregular corneas, primarily keratoconus (88%).
  • 97.7% of participants achieved successful visual rehabilitation at one month.
  • 98.5% of treated eyes gained two or more lines of vision with a median improvement of 0.30 logMAR.
  • Fitting efficiency was high, requiring an average of 1.5 lenses per eye.
  • No serious adverse events were reported, and safety findings were reassuring.
  • 90% of participants rated comfort and vision highly after three months.

Clinical Implications

The findings support the use of scleral lenses for visual rehabilitation in Chinese patients with irregular corneas.

Conclusion

This study provides evidence for the efficacy and safety of scleral lenses in a Chinese population.

Related Resources & Content

  1. Chinese Trial Validates Scleral Lenses, Eye Discovery, 2023 -- Clinical outcomes of Chinese eyes with irregular corneas managed with a scleral lens
  2. Contact Lens Spectrum, CONTACT LENS CASE REPORTS, 2019 -- How Do Scleral Lenses Treat Ocular Surface Disease?
  3. Contact Lens Spectrum, Fitting Scleral Lenses, 2006 -- Scleral Lenses
  4. Contact Lens Spectrum, THE SCLERAL LENS VAULT, 2022 -- Scleral Fitting in a Keratoglobus Patient
  5. Keratoconus 7, NCBI -- Keratoconus
  6. contact lens spectrum — POINT/COUNTERPOINT: SCLERALS FOR HEALTHY EYES
  7. Keratoconus 7 (Concept Id: C3553308) - MedGen - NCBI
  8. Clinical outcomes of Chinese eyes with irregular corneas managed with a scleral lens - ScienceDirect
  9. Corneal and Intraocular Pressure Responses to Scleral Lens Wear: A Meta-Analysis - PMC

This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.

Related Content

Newsletters

Receive the latest Ophthalmology news, personalities, education, and career development – weekly to your inbox.

Newsletter Signup Image

False

Advertisement

False

Advertisement

Explore More in Ophthalmology

Dive deeper into the world of Ophthalmology. Explore the latest articles, case studies, expert insights, and groundbreaking research.

False

Advertisement
The Ophthalmologist
Subscribe

About

  • About Us
  • Work at Conexiant Europe
  • Terms and Conditions
  • Privacy Policy
  • Advertise With Us
  • Contact Us

Copyright © 2025 Texere Publishing Limited (trading as Conexiant), with registered number 08113419 whose registered office is at Booths No. 1, Booths Park, Chelford Road, Knutsford, England, WA16 8GS.

Affiliations:

Specialties:

Areas of Expertise:

Contributions:

Disclaimer

The Ophthalmologist website is intended solely for the eyes of healthcare professionals. Please confirm below: